You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

CENESTIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Cenestin patents expire, and when can generic versions of Cenestin launch?

Cenestin is a drug marketed by Aspen and is included in one NDA.

The generic ingredient in CENESTIN is estrogens, conjugated synthetic a. There are three drug master file entries for this compound. Additional details are available on the estrogens, conjugated synthetic a profile page.

Summary for CENESTIN
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 26
Clinical Trials: 1
Patent Applications: 1,042
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in CENESTIN?CENESTIN excipients list
DailyMed Link:CENESTIN at DailyMed
Drug patent expirations by year for CENESTIN
Drug Sales Revenue Trends for CENESTIN

See drug sales revenues for CENESTIN

Recent Clinical Trials for CENESTIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Duramed ResearchPhase 3

See all CENESTIN clinical trials

Paragraph IV (Patent) Challenges for CENESTIN
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
CENESTIN Tablets estrogens, conjugated synthetic a 0.3 mg, 0.45 mg and 0.9 mg 020992 1 2009-03-19
CENESTIN Tablets estrogens, conjugated synthetic a 0.625 mg 020992 1 2009-03-02
CENESTIN Tablets estrogens, conjugated synthetic a 1.25 mg 020992 1 2008-11-03

US Patents and Regulatory Information for CENESTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aspen CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-001 Jun 21, 2002 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Aspen CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-003 Mar 24, 1999 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Aspen CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-005 Feb 5, 2004 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Aspen CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-002 Mar 24, 1999 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Aspen CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-004 Mar 13, 2000 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CENESTIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aspen CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-001 Jun 21, 2002 ⤷  Try a Trial ⤷  Try a Trial
Aspen CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-005 Feb 5, 2004 ⤷  Try a Trial ⤷  Try a Trial
Aspen CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-004 Mar 13, 2000 ⤷  Try a Trial ⤷  Try a Trial
Aspen CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-003 Mar 24, 1999 ⤷  Try a Trial ⤷  Try a Trial
Aspen CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-002 Mar 24, 1999 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for CENESTIN

See the table below for patents covering CENESTIN around the world.

Country Patent Number Title Estimated Expiration
Germany 69637601 ⤷  Try a Trial
Canada 2227887 COMPOSITIONS PHARMACEUTIQUES D'OESTROGENES CONJUGUES ET LEURS PROCEDES D'UTILISATION (PHARMACEUTICAL COMPOSITIONS OF CONJUGATED ESTROGENS AND METHODS FOR THEIR USE) ⤷  Try a Trial
China 1197387 ⤷  Try a Trial
European Patent Office 0840599 COMPOSITIONS PHARMACEUTIQUES D'OESTROGENES CONJUGUES ET LEURS PROCEDES D'UTILISATION (PHARMACEUTICAL COMPOSITIONS OF CONJUGATED ESTROGENS AND METHODS FOR THEIR USE) ⤷  Try a Trial
China 100421652 ⤷  Try a Trial
Austria 401062 ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 9704753 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.